Skip to main content
SpringerLink
Log in

Is there a role for oral rapamycin in restenosis prevention after bare-metal stent implantation?

  • Practice Point
  • Published:

From Nature Clinical Practice Cardiovascular Medicine

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Schühlen H et al. (2004) Restenosis detected by routine angiographic follow-up and late mortality after coronary stent placement. Am Heart J 147: 317–322

    Article  Google Scholar 

  2. Gallo R et al. (1999) Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle. Circulation 99: 2164–2170

    Article  CAS  Google Scholar 

  3. Moses JW et al. (2003) Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349: 1315–1323

    Article  CAS  Google Scholar 

  4. Hausleiter J et al. (2004) Randomized, double-blind, placebo-controlled trial of oral sirolimus for restenosis prevention in patients with in-stent restenosis: the Oral Sirolimus to Inhibit Recurrent In-stent Stenosis (OSIRIS) trial. Circulation 110: 790–795

    Article  CAS  Google Scholar 

  5. Kastrati A et al. (2005) Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial. JAMA 293: 165–171

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Hannah Camm, Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Associate Professor of Medicine, interventional cardiologists at the Deutsches Herzzentrum, Technische Universität, Munich, Germany

    Jörg Hausleiter & Adnan Kastrati

  2. Professor of Medicine, interventional cardiologists at the Deutsches Herzzentrum, Technische Universität, Munich, Germany

    Adnan Kastrati

Authors
  1. Jörg Hausleiter
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Adnan Kastrati
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Adnan Kastrati.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hausleiter, J., Kastrati, A. Is there a role for oral rapamycin in restenosis prevention after bare-metal stent implantation?. Nat Rev Cardiol 3, 476–477 (2006). https://doi.org/10.1038/ncpcardio0633

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpcardio0633

  • Springer Nature Limited

Search

Navigation